Arvee Laboratories (India) Ltd. (NSE:ARVEE)

Market Cap	2.18B +23.1%
Revenue (ttm)	412.59M +16.7%
Net Income	40.51M +194.8%
EPS	3.70 +197.4%
Shares Out	11.02M
PE Ratio	53.18
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,558
Open	204.29
Previous Close	202.90
Day's Range	196.21 - 204.29
52-Week Range	129.11 - 290.78
Beta	0.50
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 3, 2026

About NSE:ARVEE

Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinit...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2012
• Employees: 57
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ARVEE

Financial Performance

In fiscal year 2026, NSE:ARVEE's revenue was 315.14 million, a decrease of -18.12% compared to the previous year's 384.87 million. Earnings were 25.26 million, an increase of 17.65%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 22, 2026

Data Sources Report a data error